5 items4 sources3 stocks
J-Star Holding via GlobeNewswire-Nov 15, 12:00 PM
Alpha Tau Medical Announces Positive Interim Results from U.S. REGAIN Trial for Recurrent Glioblastoma
Alpha Tau Medical reported updated interim results from its U.S. REGAIN trial, showing all eight treated patients remain alive with no unanticipated serious adverse events.
J-Star Holding via GlobeNewswire-Nov 12, 12:00 PM
Alpha Tau Medical to Host Conference Call to Discuss REGAIN Trial Interim Results
Alpha Tau Medical announced it will hold a conference call and webcast on November 16, 2026, to review new interim data from its REGAIN clinical trial for recurrent glioblastoma.